CRDF

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Cardiff Oncology Inc

NASDAQ | CRDF

2.26

USD

$0.00

(

0.00%

)

At Close (As of Nov 28, 2025)

$157.62M

Market Cap

-

P/E Ratio

-0.79

EPS

$5.64

52 Week High

$1.90

52 Week Low

HEALTHCARE

Sector

CRDF Chart

Recent Chart
Price Action

CRDF Technicals

Tags:

CRDF Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $683K
Total Revenue $683K
Cost Of Revenue $404K
Costof Goods And Services Sold $404K
Operating Income -$49M
Selling General And Administrative $12M
Research And Development $37M
Operating Expenses $49M
Investment Income Net -
Net Interest Income $3.3M
Interest Income $3.3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $404K
Income Before Tax -$45M
Income Tax Expense -$24K
Interest And Debt Expense -
Net Income From Continuing Operations -$45M
Comprehensive Income Net Of Tax -
Ebit -$49M
Ebitda -$48M
Net Income -$45M

Revenue & Profitability

Earnings Performance

CRDF Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $97M
Total Current Assets $95M
Cash And Cash Equivalents At Carrying Value $51M
Cash And Short Term Investments $51M
Inventory -
Current Net Receivables $773K
Total Non Current Assets $2.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $40M
Other Current Assets $2.5M
Other Non Current Assets -
Total Liabilities $14M
Total Current Liabilities $13M
Current Accounts Payable $4.8M
Deferred Revenue -
Current Debt -
Short Term Debt $710K
Total Non Current Liabilities $813K
Capital Lease Obligations $1.5M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.5M
Other Current Liabilities $7.9M
Other Non Current Liabilities -
Total Shareholder Equity $83M
Treasury Stock -
Retained Earnings -$384M
Common Stock $7K
Common Stock Shares Outstanding $48M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$38M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $404K
Capital Expenditures $80K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $14M
Cashflow From Financing $54M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$45M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $683K
Total Revenue $683K
Cost Of Revenue $404K
Costof Goods And Services Sold $404K
Operating Income -$49M
Selling General And Administrative $12M
Research And Development $37M
Operating Expenses $49M
Investment Income Net -
Net Interest Income $3.3M
Interest Income $3.3M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $404K
Income Before Tax -$45M
Income Tax Expense -$24K
Interest And Debt Expense -
Net Income From Continuing Operations -$45M
Comprehensive Income Net Of Tax -
Ebit -$49M
Ebitda -$48M
Net Income -$45M

CRDF News

CRDF Profile

Cardiff Oncology Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Cardiff Oncology, Inc. is a clinical-stage biotechnology company based in San Diego, California, dedicated to developing innovative, targeted therapies for cancer treatment. Leveraging its proprietary technology platform, the firm advances a promising pipeline of drug candidates that aim to enhance patient outcomes for various malignancies. By focusing on addressing significant unmet medical needs in oncology, Cardiff Oncology is strategically positioned to make meaningful contributions to cancer care, potentially transforming treatment paradigms for patients on a global scale.

LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
ADAP
-15.14%
$0.05
HOOD
+10.92%
$128.20
INTC
+7.72%
$39.65
RUBI
-25.80%
$0.16
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ASST
+2.65%
$1.16
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
INHD
-1.55%
$0.22
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
SNAP
+0.14%
$7.62
ONMD
+45.07%
$2.06
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
CIFR
+10.05%
$21.07
PLUG
+2.09%
$2.02
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
DEFT
+11.51%
$1.55
NIO
+0.36%
$5.48
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
F
+0.68%
$13.28
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
GOOGL
-0.60%
$318.02
SOFI
+3.18%
$29.39
VALE
+0.31%
$12.54
BTG
+3.37%
$4.62
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
DVLT
-6.33%
$1.99
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
IBRX
+11.50%
$2.37
CAN
+12.59%
$1.03
WULF
+5.18%
$15.61
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NGD
+5.86%
$8.30
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBI
-0.75%
$6.54
APLD
+7.21%
$26.74
PFE
+0.19%
$25.75
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
AMD
+0.97%
$216.32
CRCG
+21.27%
$2.85
KO
+0.37%
$72.88
TMC
+14.32%
$6.66
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
SNDK
+4.28%
$224.25
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
PLTR
+0.75%
$167.01
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
ZIM
+0.97%
$19.70
LPTX
+368.57%
$2.05
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
KTTA
+54.72%
$1.64
VINE
+10.76%
$0.39
AMZE
+28.66%
$0.50
IPG
-1.95%
$24.57
TLRY
-20.11%
$0.82
NVDA
-1.76%
$177.08
AXDX
-61.36%
$0.03
YGMZ
-10.65%
$0.10
BITF
+11.80%
$3.46
ADAP
-15.14%
$0.05
HOOD
+10.92%
$128.20
INTC
+7.72%
$39.65
RUBI
-25.80%
$0.16
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ASST
+2.65%
$1.16
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
BIYA
+11.30%
$0.28
AGNC
+1.53%
$10.56
BAC
+0.97%
$52.99
CLSK
+14.57%
$15.41
TWOH
0.00%
$0.00
INHD
-1.55%
$0.22
WLGS
-5.57%
$0.04
BMNR
+6.26%
$33.72
MTSR
-0.35%
$70.50
SNAP
+0.14%
$7.62
ONMD
+45.07%
$2.06
TSLA
+0.55%
$428.96
PCG
+1.78%
$16.01
CIFR
+10.05%
$21.07
PLUG
+2.09%
$2.02
AFMD
-34.94%
$0.18
ADTX
+18.78%
$3.72
MARA
+5.02%
$11.66
GPUS
-6.69%
$0.31
NVTS
+3.86%
$8.34
DEFT
+11.51%
$1.55
NIO
+0.36%
$5.48
KWM
+12.77%
$0.74
CHR
-4.18%
$0.04
BMNU
+14.89%
$8.64
F
+0.68%
$13.28
GRYP
-10.38%
$1.38
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
ONDS
-2.81%
$8.00
TEVA
+5.32%
$26.32
GOOGL
-0.60%
$318.02
SOFI
+3.18%
$29.39
VALE
+0.31%
$12.54
BTG
+3.37%
$4.62
CRCL
+11.05%
$80.67
KDLY
+7.20%
$0.49
AAL
+0.60%
$14.01
DVLT
-6.33%
$1.99
SMX
+222.58%
$56.13
CSCO
-0.32%
$76.07
IBRX
+11.50%
$2.37
CAN
+12.59%
$1.03
WULF
+5.18%
$15.61
IREN
-0.44%
$48.23
BTBT
+2.58%
$2.38
BURU
+5.44%
$0.23
SAND
-6.04%
$12.12
RIOT
+9.45%
$16.37
NGD
+5.86%
$8.30
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBI
-0.75%
$6.54
APLD
+7.21%
$26.74
PFE
+0.19%
$25.75
GRAB
+2.67%
$5.46
AG
+12.27%
$15.16
GOOG
-0.73%
$317.92
AMD
+0.97%
$216.32
CRCG
+21.27%
$2.85
KO
+0.37%
$72.88
TMC
+14.32%
$6.66
C
+1.31%
$102.50
CRCA
+22.96%
$4.52
SNDK
+4.28%
$224.25
ABVE
+16.17%
$3.05
NEHC
+8.33%
$5.07
RIVN
+4.57%
$16.92
PLTR
+0.75%
$167.01
COMP
-0.76%
$10.42
CDE
+6.02%
$17.16
ACHR
+4.07%
$7.79
RF
+0.11%
$25.45
KEY
+0.16%
$18.40
MSTR
+2.73%
$180.44
DNN
+1.09%
$2.58
ZIM
+0.97%
$19.70
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.